 |
JOURNAL TOOLS |
| eTOC |
| Per abbonarsi |
| Sottometti un articolo |
| Segnala alla tua biblioteca |
ARTICLE TOOLS |
| Estratti |
| Permessi |
| Per citare questo articolo |
I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
REVIEWS PET AND GYNECOLOGICAL TUMORS
The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2016 June;60(2):93-102
Copyright © 2016 EDIZIONI MINERVA MEDICA
lingua: Inglese
Imaging biomarkers in ovarian cancer: the role of 18F-FDG PET/CT
Paola MAPELLI, Elena INCERTI, Federico FALLANCA, Luigi GIANOLLI, Maria PICCHIO ✉
Department of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy
Ovarian cancer represents one of the major form of cancer in women in the western world and its silent nature leads to a late clinical manifestation at advanced stage in many patients. Therefore the role of imaging techniques is very important for the correct management of these patients. In the present review, the role of 18F-FDG-PET/CT in the different clinical settings is presented and a comparison with other imaging modalities and serum biomarker CA-125 are discussed.